Trial
NCT03763422
Trial in Low Grade Glioma Patients: Wait or Treat
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
Cooperative Trials Group for Neuro-Oncology (COGNO)
Condition
Low-grade Glioma
Intervention
Temozolomide
Why stopped
Poorly recruiting
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-01